Medicinal Cannabis For Pharmacists (Australia)
Cannabis has a long history of recorded medicinal use, dating back to 2900 BCE. The plant contains several active compounds, including cannabinoids, terpenes, and flavonoids, that have been studied for their medicinal properties. While there are many potential therapeutic benefits, it is essential to identify and minimise potential risks. Across the world, more and more countries are legalising cannabis for medicinal purposes. Only one medicinal cannabis product, nabimixols, has been approved by the TGA at this time. The Therapeutics Goods Act 1989 (Cth) provides a number of mechanisms to enable access to unapproved therapeutic goods in Australia.
This module provides information on the pharmacology of medicinal cannabis, and indications for which recognised evidence exists, important contraindications and precautions for use, a framework for discussing medicinal cannabis with patients and guidance about who can prescribe medicinal cannabis under current regulations.
- Recognise the pharmacotherapeutic properties of medicinal cannabis;
- Identify the side effects, contraindications and precautions relating to medicinal cannabis;
- Recognise the levels of evidence currently known regarding medicinal cannabis use;
- Identify populations for whom medicinal cannabis may be beneficial and those who should not be using medicinal cannabis due to known risks;
- Recognise the regulatory, reimbursement and logistics requirements that currently apply to dispensing medicinal cannabis.
- Presenter(s):Anita Muñoz
- Host:Spectrum Therapeutics
- Activity ID:G2020008
- QI&CPD Points:1
Pharmacists are able to access this free educational module here:Launch